Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2014
10/09/2014WO2014165137A1 Compounds and methods for treating obesity and controlling weight
10/09/2014WO2014165108A1 Bioerodible silicon-based delivery vehicles for delivery of therapeutic agents
10/09/2014WO2014165103A1 Individualized high-purity glioblastoma multiforme stem cells and methods for stimulating immune response
10/09/2014WO2014165043A1 Fragments, mutants and chimeric fusion proteins of leptin for treating alzheimer's disease
10/09/2014WO2014164981A1 Modified mullerian inhibiting substance (mis) proteins and uses thereof for the treatment of diseases
10/09/2014WO2014164684A1 Protein delivery systems
10/09/2014WO2014164670A1 Protein particles comprising disulfide crosslinkers and uses related thereto
10/09/2014WO2014164669A1 Improved medical device
10/09/2014WO2014164617A1 Cosmetic use of napthoic acid derivatives
10/09/2014WO2014164568A1 Treatment of pediatric growth hormone deficiency with human growth hormone analogues
10/09/2014WO2014164464A1 High purity ovarian cancer stem cells for active autologous immune therapy
10/09/2014WO2014164462A1 Method of induction and purification of a cell population responsible for vasculary mimicry and use of the same
10/09/2014WO2014164427A1 Fusion immunomodulatory proteins and methods for making same
10/09/2014WO2014164395A1 Combination anti-estrogen receptor cancer therapy using muc1 peptides and chemotherapeutics
10/09/2014WO2014164394A1 Combination anti-her2 cancer therapy using muc1 peptides and chemotherapeutics
10/09/2014WO2014164301A2 Protein formulations
10/09/2014WO2014163684A1 Combination therapy for inducing immune response to disease
10/09/2014WO2014163535A1 Chimeric peptide and pharmaceutical composition for treating oncological diseases
10/09/2014WO2014162007A2 Thymic stromal lymphopoietin fragments and uses thereof
10/09/2014WO2014161926A1 Supramolecular aggregates comprising maleimido cores
10/09/2014WO2014161837A1 Treatment of diabetes mellitus by long–acting formulations of insulins
10/09/2014WO2014161835A1 Modified blood glucose regulating proteins with altered pharmacological activity profile and preparation thereof
10/09/2014WO2014161782A1 Beta-hairpin peptidomimetics
10/09/2014WO2014161509A1 Novel pd1 isoforms, and uses thereof for potentiating immune responses
10/09/2014WO2014161370A1 Protamine peptidomimetic, and pharmaceutically acceptable salts and use thereof
10/09/2014WO2014161284A1 Cell-penetrating polypeptides and uses thereof in drug delivery
10/09/2014WO2014161240A1 Preparation method and application of anti-tumor active polypeptide component in scapharca subcrenatae
10/09/2014WO2014161118A1 Pentapeptide, polypeptide, cyclopeptide derivative, and compound and medicament and application thereof
10/09/2014WO2014161116A1 Pa200 and acetylation mediate proteasomal degradation of core histones
10/09/2014WO2014161095A1 Crp40 fragments for the treatment of neurological disorders
10/09/2014US20140303208 Pharmaceutically active piperidine derivatives
10/09/2014US20140303094 Composition and use thereof in the treatment of anal rhagades
10/09/2014US20140303091 Ocular formulations of norketotifen
10/09/2014US20140303090 Smac Mimetic Therapy
10/09/2014US20140303089 Plant HSP70 for Use in the Treatment of Food Allergy
10/09/2014US20140303088 HSP20 Inhibits Amyloidogenesis and Neurotoxicity
10/09/2014US20140303087 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activity and use thereof
10/09/2014US20140303086 Endothelium protective materials and methods of use
10/09/2014US20140303085 Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrence
10/09/2014US20140303084 Pro-Coagulant Compounds and Methods of Use Thereof
10/09/2014US20140303081 Apoptosis-targeting nanoparticles
10/09/2014US20140303079 Delaying the Progression of Diabetes
10/09/2014US20140303077 Albumin fusion proteins
10/09/2014US20140303074 Compositions and Methods For Inhibiting Immunodeficiency Virus Transcription
10/09/2014US20140303073 Antisense antiviral compound and method for treating influenza viral infection
10/09/2014US20140303072 Method of Determining Types I, II, III, IV or V or Methicillin-resistant Staphylococcus aureus (MRSA) in a Biological Sample
10/09/2014US20140303069 Anti-Microbial Peptides and Methods of Use Thereof
10/09/2014US20140303068 Method of treating mucus hypersecretion
10/09/2014US20140303067 Treatment of eosinophilic esophagitis
10/09/2014US20140302499 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
10/09/2014US20140302171 Cysteine Peptide-Containing Health Drink
10/09/2014US20140302151 Methods and compositions for treating pain
10/09/2014US20140302142 Compositions and methds for enhancing penetration of biologically active substances into tissues or organs
10/09/2014US20140302129 Human lubrication gel
10/09/2014US20140302123 Products useful for the treatment of malignant neoplasms of the human nervous system
10/09/2014US20140302122 Fungal-specific metalloproteases and uses thereof
10/09/2014US20140302111 Compositions and methods for dental tissue regeneration
10/09/2014US20140302099 Ophthalmic Composition Containing Cyclosporine And method For Preparing Same
10/09/2014US20140302057 Inhibitors of metastasis
10/09/2014US20140302051 Biocompatible Hydrogel Polymer Formulations for the Controlled Delivery of Biomolecules
10/09/2014US20140302043 Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
10/09/2014US20140302023 Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging
10/09/2014US20140302008 Stable formulations of botulinum toxin in hydrogels
10/09/2014US20140302007 Botulinum toxin formulation
10/09/2014US20140302005 Chimeric factor vii molecules
10/09/2014US20140302004 Triple Acting Antimicrobials That Are Refractory To Resistance Development
10/09/2014US20140302002 Use of gstp1
10/09/2014US20140302001 Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
10/09/2014US20140302000 Pharmaceutical compositions of lipase-containing products, in particular of pancreatin
10/09/2014US20140301982 Complement antagonists and uses thereof
10/09/2014US20140301981 Combination Therapy with Interferon and Andrographolides for Multiple Sclerosis
10/09/2014US20140301973 Combination therapies for treating type 1 diabetes
10/09/2014US20140301951 Porous nanoparticle supported lipid nanostructures
10/08/2014EP2787007A2 Subcutaneously administered ANTI-IL-6 receptor antibody
10/08/2014EP2786766A1 Supramolecular aggregates comprising maleimido cores
10/08/2014EP2786761A1 Pharmaceutical preparation
10/08/2014EP2786756A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786755A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786754A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786753A2 Combination therapy with an antitumor alkaloid
10/08/2014EP2786746A1 Stabilizing a Liquid Formulation Containing a Protein Drug
10/08/2014EP2785744A1 Protein inhibitors to complement and vegf pathways and methods of use thereof
10/08/2014EP2785733A1 Inotropic compounds
10/08/2014EP2785420A1 Collagen hydrolysate and use thereof
10/08/2014EP2785406A1 Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same
10/08/2014EP2785382A1 Multivalent antibody complexes targeting igf-1r show potent toxicity against solid tumors
10/08/2014EP2785379A1 Peptide-mediated delivery of active agents across the blood-brain barrier
10/08/2014EP2785377A1 A method to enhance cognition
10/08/2014EP2785367A1 Therapeutic agents comprising insulin amino acid sequences
10/08/2014EP2785366A1 Insulin glargine versus metformin for the first-line treatment of early type 2 diabetes
10/08/2014EP2785365A1 Pharmaceutical composition for use in the treatment of dysfunction associated with aging
10/08/2014EP2785364A1 Use of p3 of bacteriophage as amyloid binding agents
10/08/2014EP2785363A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome
10/08/2014EP2785362A2 Anticancer fusion protein
10/08/2014EP2785359A1 Mesenchymal stromal cells and uses related thereto
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853367 Compositions and methods for modulating rank activities
10/07/2014US8853366 Binding domain-immunoglobulin fusion proteins
10/07/2014US8853361 Preparation, for use, in particular, for tissue augmentation and healing
10/07/2014US8853359 Endokinin C/D-derived peptides
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 3163